Please login to the form below

Not currently logged in
Email:
Password:

James D'Arecca joins Actavis

Moves from Bausch & Lomb to take up accounting role

James D'Arecca has moved from eyecare firm Bausch & Lomb to join generic company Actavis as its new chief accounting officer.

He served in a similar role at Bausch & Lomb and in his new position will report to Actavis' chief financial officer R Todd Joyce.

Prior to Bausch & Lomb, he worked for Merck & Co, where he served as executive director and business development controller.

In this role, he was the primary liaison between the controller's organisation and the business development and corporate licensing functions.

Prior to joining Merck, D'Arecca was executive director and assistant controller at Schering-Plough, which Merck acquired in 2009.

His career to date has also included 13 years with PricewaterhouseCoopers, where his industry focus was on pharmaceuticals, medical devices and consumer products.

20th August 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMR

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics